Dale Webster

Dale Webster

Dale Webster is Director in Google Research working to improve patient outcomes in healthcare using Deep Learning and Medical Imaging. His work Includes leveraging AI to screen for Diabetic Retinopathy in India and Thailand, predicting Cardiovascular health factors from fundus photos, differential diagnosis of skin disease, and applications of medically tuned LLMs. Prior to Google he was a Software Engineer at Pacific Biosciences working on direct sequencing of methylation state and rapid sequencing and assembly of microbial pathogens during global outbreaks. His PhD work in Bioinformatics at the University of California San Francisco focused on viral evolution, and he received his Bachelor of Science in Computer Science from Rice University.
Authored Publications
Sort By
  • Title
  • Title, descending
  • Year
  • Year, descending
    Validation of a Deep Learning Model for Diabetic Retinopathy on Patients with Young-Onset Diabetes
    Tony Tan-Torres
    Pradeep Praveen
    Divleen Jeji
    Arthur Brant
    Xiang Yin
    Lu Yang
    Tayyeba Ali
    Ilana Traynis
    Dushyantsinh Jadeja
    Rajroshan Sawhney
    Sunny Virmani
    Pradeep Venkatesh
    Nikhil Tandon
    Ophthalmology and Therapy (2025)
    Preview abstract Introduction While many deep learning systems (DLSs) for diabetic retinopathy (DR) have been developed and validated on cohorts with an average age of 50s or older, fewer studies have examined younger individuals. This study aimed to understand DLS performance for younger individuals, who tend to display anatomic differences, such as prominent retinal sheen. This sheen can be mistaken for exudates or cotton wool spots, and potentially confound DLSs. Methods This was a prospective cross-sectional cohort study in a “Diabetes of young” clinic in India, enrolling 321 individuals between ages 18 and 45 (98.8% with type 1 diabetes). Participants had fundus photographs taken and the photos were adjudicated by experienced graders to obtain reference DR grades. We defined a younger cohort (age 18–25) and an older cohort (age 26–45) and examined differences in DLS performance between the two cohorts. The main outcome measures were sensitivity and specificity for DR. Results Eye-level sensitivity for moderate-or-worse DR was 97.6% [95% confidence interval (CI) 91.2, 98.2] for the younger cohort and 94.0% [88.8, 98.1] for the older cohort (p = 0.418 for difference). The specificity for moderate-or-worse DR significantly differed between the younger and older cohorts, 97.9% [95.9, 99.3] and 92.1% [87.6, 96.0], respectively (p = 0.008). Similar trends were observed for diabetic macular edema (DME); sensitivity was 79.0% [57.9, 93.6] for the younger cohort and 77.5% [60.8, 90.6] for the older cohort (p = 0.893), whereas specificity was 97.0% [94.5, 99.0] and 92.0% [88.2, 95.5] (p = 0.018). Retinal sheen presence (94% of images) was associated with DME presence (p < 0.0001). Image review suggested that sheen presence confounded reference DME status, increasing noise in the labels and depressing measured sensitivity. The gradability rate for both DR and DME was near-perfect (99% for both). Conclusion DLS-based DR screening performed well in younger individuals aged 18–25, with comparable sensitivity and higher specificity compared to individuals aged 26–45. Sheen presence in this cohort made identification of DME difficult for graders and depressed measured DLS sensitivity; additional studies incorporating optical coherence tomography may improve accuracy of measuring DLS DME sensitivity. View details
    LLM-based Lossless Text Simplification and its Effect on User Comprehension and Cognitive Load
    Theo Guidroz
    Diego Ardila
    Jimmy Li
    Adam Mansour
    Paul Jhun
    Nina Gonzalez
    Xiang Ji
    Mike Sanchez
    Miguel Ángel Garrido
    Divyansh Choudhary
    Jay Hartford
    Georgina Xu
    Henry Serrano
    Yifan Wang
    Jeff Shaffer
    Eric (Yifan) Cao
    Sho Fujiwara
    Peggy Bui
    arXiv (2025)
    Preview abstract Information on the web, such as scientific publications and Wikipedia, often surpasses users' reading level. To help address this, we used a self-refinement approach to develop a LLM capability for minimally lossy text simplification. To validate our approach, we conducted a randomized study involving 4563 participants and 31 texts spanning 6 broad subject areas: PubMed (biomedical scientific articles), biology, law, finance, literature/philosophy, and aerospace/computer science. Participants were randomized to viewing original or simplified texts in a subject area, and answered multiple-choice questions (MCQs) that tested their comprehension of the text. The participants were also asked to provide qualitative feedback such as task difficulty. Our results indicate that participants who read the simplified text answered more MCQs correctly than their counterparts who read the original text (3.9% absolute increase, p<0.05). This gain was most striking with PubMed (14.6%), while more moderate gains were observed for finance (5.5%), aerospace/computer science (3.8%) domains, and legal (3.5%). Notably, the results were robust to whether participants could refer back to the text while answering MCQs. The absolute accuracy decreased by up to ~9% for both original and simplified setups where participants could not refer back to the text, but the ~4% overall improvement persisted. Finally, participants' self-reported perceived ease based on a simplified NASA Task Load Index was greater for those who read the simplified text (absolute change on a 5-point scale 0.33, p<0.05). This randomized study, involving an order of magnitude more participants than prior works, demonstrates the potential of LLMs to make complex information easier to understand. Our work aims to enable a broader audience to better learn and make use of expert knowledge available on the web, improving information accessibility. View details
    Preview abstract Generative Artificial Intelligence (AI), particularly Large Language Models (LLMs), have demonstrated significant potential in clinical reasoning skills such as history-taking and differential diagnosis generation—critical aspects of medical education. This work explores how LLMs can augment medical curricula through interactive learning. We conducted a participatory design process with medical students, residents and medical education experts to co-create an AI-powered tutor prototype for clinical reasoning. As part of the co-design process, we conducted a qualitative user study, investigating learning needs and practices via interviews, and conducting concept evaluations through interactions with the prototype. Findings highlight the challenges learners face in transitioning from theoretical knowledge to practical application, and how an AI tutor can provide personalized practice and feedback. We conclude with design considerations, emphasizing the importance of context-specific knowledge and emulating positive preceptor traits, to guide the development of AI tools for medical education. View details
    Performance of a Deep Learning Diabetic Retinopathy Algorithm in India
    Arthur Brant
    Xiang Yin
    Lu Yang
    Jay Nayar
    Divleen Jeji
    Sunny Virmani
    Anchintha Meenu
    Naresh Babu Kannan
    Florence Thng
    Lily Peng
    Ramasamy Kim
    JAMA Network Open (2025)
    Preview abstract Importance: While prospective studies have investigated the accuracy of artificial intelligence (AI) for detection of diabetic retinopathy (DR) and diabetic macular edema (DME), to date, little published data exist on the clinical performance of these algorithms. Objective: To evaluate the clinical performance of an automated retinal disease assessment (ARDA) algorithm in the postdeployment setting at Aravind Eye Hospital in India. Design, Setting, and Participants: This cross-sectional analysis involved an approximate 1% sample of fundus photographs from patients screened using ARDA. Images were graded via adjudication by US ophthalmologists for DR and DME, and ARDA’s output was compared against the adjudicated grades at 45 sites in Southern India. Patients were randomly selected between January 1, 2019, and July 31, 2023. Main Outcomes and Measures: Primary analyses were the sensitivity and specificity of ARDA for severe nonproliferative DR (NPDR) or proliferative DR (PDR). Secondary analyses focused on sensitivity and specificity for sight-threatening DR (STDR) (DME or severe NPDR or PDR). Results: Among the 4537 patients with 4537 images with adjudicated grades, mean (SD) age was 55.2 (11.9) years and 2272 (50.1%) were male. Among the 3941 patients with gradable photographs, 683 (17.3%) had any DR, 146 (3.7%) had severe NPDR or PDR, 109 (2.8%) had PDR, and 398 (10.1%) had STDR. ARDA’s sensitivity and specificity for severe NPDR or PDR were 97.0% (95% CI, 92.6%-99.2%) and 96.4% (95% CI, 95.7%-97.0%), respectively. Positive predictive value (PPV) was 50.7% and negative predictive value (NPV) was 99.9%. The clinically important miss rate for severe NPDR or PDR was 0% (eg, some patients with severe NPDR or PDR were interpreted as having moderate DR and referred to clinic). ARDA’s sensitivity for STDR was 95.9% (95% CI, 93.0%-97.4%) and specificity was 94.9% (95% CI, 94.1%-95.7%); PPV and NPV were 67.9% and 99.5%, respectively. Conclusions and Relevance: In this cross-sectional study investigating the clinical performance of ARDA, sensitivity and specificity for severe NPDR and PDR exceeded 96% and caught 100% of patients with severe  NPDR and PDR for ophthalmology referral. This preliminary large-scale postmarketing report of the performance of ARDA after screening 600 000 patients in India underscores the importance of monitoring and publication an algorithm's clinical performance, consistent with recommendations by regulatory bodies. View details
    Preview abstract While large language models (LLMs) have shown promise in diagnostic dialogue, their capabilities for effective management reasoning - including disease progression, therapeutic response, and safe medication prescription - remain under-explored. We advance the previously demonstrated diagnostic capabilities of the Articulate Medical Intelligence Explorer (AMIE) through a new LLM-based agentic system optimised for clinical management and dialogue, incorporating reasoning over the evolution of disease and multiple patient visit encounters, response to therapy, and professional competence in medication prescription. To ground its reasoning in authoritative clinical knowledge, AMIE leverages Gemini's long-context capabilities, combining in-context retrieval with structured reasoning to align its output with relevant and up-to-date clinical practice guidelines and drug formularies. In a randomized, blinded virtual Objective Structured Clinical Examination (OSCE) study, AMIE was compared to 21 primary care physicians (PCPs) across 100 multi-visit case scenarios designed to reflect UK NICE Guidance and BMJ Best Practice guidelines. AMIE was non-inferior to PCPs in management reasoning as assessed by specialist physicians and scored better in both preciseness of treatments and investigations, and in its alignment with and grounding of management plans in clinical guidelines. To benchmark medication reasoning, we developed RxQA, a multiple-choice question benchmark derived from two national drug formularies (US, UK) and validated by board-certified pharmacists. While AMIE and PCPs both benefited from the ability to access external drug information, AMIE outperformed PCPs on higher difficulty questions. While further research would be needed before real-world translation, AMIE's strong performance across evaluations marks a significant step towards conversational AI as a tool in disease management. View details
    Closing the AI generalisation gap by adjusting for dermatology condition distribution differences across clinical settings
    Rajeev Rikhye
    Aaron Loh
    Grace Hong
    Margaret Ann Smith
    Vijaytha Muralidharan
    Doris Wong
    Michelle Phung
    Nicolas Betancourt
    Bradley Fong
    Rachna Sahasrabudhe
    Khoban Nasim
    Alec Eschholz
    Basil Mustafa
    Jan Freyberg
    Terry Spitz
    Kat Chou
    Peggy Bui
    Justin Ko
    Steven Lin
    The Lancet eBioMedicine (2025)
    Preview abstract Background: Generalisation of artificial intelligence (AI) models to a new setting is challenging. In this study, we seek to understand the robustness of a dermatology (AI) model and whether it generalises from telemedicine cases to a new setting including both patient-submitted photographs (“PAT”) and clinician-taken photographs in-clinic (“CLIN”). Methods: A retrospective cohort study involving 2500 cases previously unseen by the AI model, including both PAT and CLIN cases, from 22 clinics in the San Francisco Bay Area, spanning November 2015 to January 2021. The primary outcome measure for the AI model and dermatologists was the top-3 accuracy, defined as whether their top 3 differential diagnoses contained the top reference diagnosis from a panel of dermatologists per case. Findings: The AI performed similarly between PAT and CLIN images (74% top-3 accuracy in CLIN vs. 71% in PAT), however, dermatologists were more accurate in PAT images (79% in CLIN vs. 87% in PAT). We demonstrate that demographic factors were not associated with AI or dermatologist errors; instead several categories of conditions were associated with AI model errors (p < 0.05). Resampling CLIN and PAT to match skin condition distributions to the AI development dataset reduced the observed differences (AI: 84% CLIN vs. 79% PAT; dermatologists: 77% CLIN vs. 89% PAT). We demonstrate a series of steps to close the generalisation gap, requiring progressively more information about the new dataset, ranging from the condition distribution to additional training data for rarer conditions. When using additional training data and testing on the dataset without resampling to match AI development, we observed comparable performance from end-to-end AI model fine tuning (85% in CLIN vs. 83% in PAT) vs. fine tuning solely the classification layer on top of a frozen embedding model (86% in CLIN vs. 84% in PAT). Interpretation: AI algorithms can be efficiently adapted to new settings without additional training data by recalibrating the existing model, or with targeted data acquisition for rarer conditions and retraining just the final layer. View details
    Safety principles for medical summarization using generative AI
    Dillon Obika
    Christopher Kelly
    Nicola Ding
    Chris Farrance
    Praney Mittal
    Donny Cheung
    Heather Cole-Lewis
    Madeleine Elish
    Nature Medicine (2024)
    Preview abstract The introduction of Generative AI, particularly large language models presents exciting opportunities for healthcare. However their novel capabilities also have the potential to introduce novel risks and hazards. This paper explores the unique safety challenges associated with LLMs in healthcare, using medical text summarization as a motivating example. Using MedLM as a case example, we propose leveraging existing standards and guidance while developing novel approaches tailored to the specific characteristics of LLMs. View details
    Creating an Empirical Dermatology Dataset Through Crowdsourcing With Web Search Advertisements
    Abbi Ward
    Jimmy Li
    Julie Wang
    Sriram Lakshminarasimhan
    Ashley Carrick
    Jay Hartford
    Pradeep Kumar S
    Sunny Virmani
    Renee Wong
    Margaret Ann Smith
    Dawn Siegel
    Steven Lin
    Justin Ko
    JAMA Network Open (2024)
    Preview abstract Importance: Health datasets from clinical sources do not reflect the breadth and diversity of disease, impacting research, medical education, and artificial intelligence tool development. Assessments of novel crowdsourcing methods to create health datasets are needed. Objective: To evaluate if web search advertisements (ads) are effective at creating a diverse and representative dermatology image dataset. Design, Setting, and Participants: This prospective observational survey study, conducted from March to November 2023, used Google Search ads to invite internet users in the US to contribute images of dermatology conditions with demographic and symptom information to the Skin Condition Image Network (SCIN) open access dataset. Ads were displayed against dermatology-related search queries on mobile devices, inviting contributions from adults after a digital informed consent process. Contributions were filtered for image safety and measures were taken to protect privacy. Data analysis occurred January to February 2024. Exposure: Dermatologist condition labels as well as estimated Fitzpatrick Skin Type (eFST) and estimated Monk Skin Tone (eMST) labels. Main Outcomes and Measures: The primary metrics of interest were the number, quality, demographic diversity, and distribution of clinical conditions in the crowdsourced contributions. Spearman rank order correlation was used for all correlation analyses, and the χ2 test was used to analyze differences between SCIN contributor demographics and the US census. Results: In total, 5749 submissions were received, with a median of 22 (14-30) per day. Of these, 5631 (97.9%) were genuine images of dermatological conditions. Among contributors with self-reported demographic information, female contributors (1732 of 2596 contributors [66.7%]) and younger contributors (1329 of 2556 contributors [52.0%] aged <40 years) had a higher representation in the dataset compared with the US population. Of 2614 contributors who reported race and ethnicity, 852 (32.6%) reported a racial or ethnic identity other than White. Dermatologist confidence in assigning a differential diagnosis increased with the number of self-reported demographic and skin-condition–related variables (Spearman R = 0.1537; P < .001). Of 4019 contributions reporting duration since onset, 2170 (54.0%) reported onset within less than 7 days of submission. Of the 2835 contributions that could be assigned a dermatological differential diagnosis, 2523 (89.0%) were allergic, infectious, or inflammatory conditions. eFST and eMST distributions reflected the geographical origin of the dataset. Conclusions and Relevance: The findings of this survey study suggest that search ads are effective at crowdsourcing dermatology images and could therefore be a useful method to create health datasets. The SCIN dataset bridges important gaps in the availability of images of common, short-duration skin conditions. View details
    Towards Generalist Biomedical AI
    Danny Driess
    Andrew Carroll
    Chuck Lau
    Ryutaro Tanno
    Ira Ktena
    Basil Mustafa
    Aakanksha Chowdhery
    Simon Kornblith
    Philip Mansfield
    Sushant Prakash
    Renee Wong
    Sunny Virmani
    Sara Mahdavi
    Bradley Green
    Ewa Dominowska
    Joelle Barral
    Karan Singhal
    Pete Florence
    NEJM AI (2024)
    Preview abstract BACKGROUND: Medicine is inherently multimodal, requiring the simultaneous interpretation and integration of insights between many data modalities spanning text, imaging, genomics, and more. Generalist biomedical artificial intelligence systems that flexibly encode, integrate, and interpret these data might better enable impactful applications ranging from scientific discovery to care delivery. METHODS: To catalyze development of these models, we curated MultiMedBench, a new multimodal biomedical benchmark. MultiMedBench encompasses 14 diverse tasks, such as medical question answering, mammography and dermatology image interpretation, radiology report generation and summarization, and genomic variant calling. We then introduced Med-PaLM Multimodal (Med-PaLM M), our proof of concept for a generalist biomedical AI system that flexibly encodes and interprets biomedical data including clinical language, imaging, and genomics with the same set of model weights. To further probe the capabilities and limitations of Med-PaLM M, we conducted a radiologist evaluation of model-generated (and human) chest x-ray reports. RESULTS: We observed encouraging performance across model scales. Med-PaLM M reached performance competitive with or exceeding the state of the art on all MultiMedBench tasks, often surpassing specialist models by a wide margin. In a side-by-side ranking on 246 retrospective chest x-rays, clinicians expressed a pairwise preference for Med-PaLM Multimodal reports over those produced by radiologists in up to 40.50% of cases, suggesting potential clinical utility. CONCLUSIONS: Although considerable work is needed to validate these models in real-world cases and understand if cross-modality generalization is possible, our results represent a milestone toward the development of generalist biomedical artificial intelligence systems. View details
    Conversational AI in health: Design considerations from a Wizard-of-Oz dermatology case study with users, clinicians and a medical LLM
    Brenna Li
    Amy Wang
    Patricia Strachan
    Julie Anne Seguin
    Sami Lachgar
    Karyn Schroeder
    Renee Wong
    Extended Abstracts of the 2024 CHI Conference on Human Factors in Computing Systems, Association for Computing Machinery, pp. 10
    Preview abstract Although skin concerns are common, access to specialist care is limited. Artificial intelligence (AI)-assisted tools to support medical decisions may provide patients with feedback on their concerns while also helping ensure the most urgent cases are routed to dermatologists. Although AI-based conversational agents have been explored recently, how they are perceived by patients and clinicians is not well understood. We conducted a Wizard-of-Oz study involving 18 participants with real skin concerns. Participants were randomly assigned to interact with either a clinician agent (portrayed by a dermatologist) or an LLM agent (supervised by a dermatologist) via synchronous multimodal chat. In both conditions, participants found the conversation to be helpful in understanding their medical situation and alleviate their concerns. Through qualitative coding of the conversation transcripts, we provide insight on the importance of empathy and effective information-seeking. We conclude with design considerations for future AI-based conversational agents in healthcare settings. View details